Note: Ingredients listed on restricted chemical lists
EC/CAS
101-68-8
Name of the chemical
4,4’-Methylenediphenyl diisocyanate
Concentration
20-25% 15-20%
EC/CAS
26447-40-5
Name of the chemical
Methylenediphenyl diisocyanate (see also specific isomers)
Concentration
10-15%
EC/CAS
1333-86-4
Name of the chemical
carbon black
Concentration
0.1-0.9%
General Information
Revision date
2022-11-01
Product name
LORD 7150 A
1.2.1 Relevant identified uses
Urethane Adhesive, Part 1 of 2 LORD Corporation 111 LORD Drive Cary, NC 27511-7923 USA
Emergency telephone
800 424-9300, 703 527-3887
Icons in SDS
Company Information
company name
LORD Corporation
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H315, H317, H319, H332, H334, H335, H351, H370, H372
Hazard statements
Code
Statements
H315
Causes skin irritation
Section 2
SECTION 2: Hazards identification
GHS CLASSIFICATION Acute toxicity Inhalation - Dust and MistCategory 4 - 13.3% of the mixture consists of ingredient(s) of unknown toxicity Acute toxicity Inhalation - Vapour Category 4 - 13.3% of the mixture consists of ingredient(s) of unknown toxicity Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2A Skin sensitization Category 1 Respiratory sensitization Category 1 Carcinogenicity Category 2 Specific target organ systemic toxicity (single exposure) Category 3 Specific target organ systemic toxicity (single exposure) Category 1 Respiratory system Specific target organ systemic toxicity (repeated exposure) Category 1 Respiratory system
Signal word
DANGER
Hazard statements
Harmful if inhaled. Causes skin irritation. Causes serious eye irritation. May cause an allergic skin reaction. May cause allergy or asthma symptoms or breathing difficulties if inhaled. Suspected of causing cancer. May cause respiratory irritation. Causes damage to organs.(Respiratory system) Causes damage to organs through prolonged or repeated exposure.(Respiratory system)
Prevention
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Wear protective gloves, eye protection, face protection. 300001001832 Use personal protective equipment as required. In case of inadequate ventilation wear respiratory protection. Do not breathe dust, fume, mist, vapors, spray. Wash thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Contaminated work clothing should not be allowed out of the workplace.
Response
Call a POISON CENTER or doctor, physician if you feel unwell. IF exposed: Call a POISON CENTER or doctor, physician. Specific treatment (see supplemental first aid instructions on this label). IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. If experiencing respiratory symptoms: Call a POISON CENTER or doctor, physician. IF ON SKIN: Wash with plenty of soap and water. If skin irritation or rash occurs: Get medical advice, attention. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Take off contaminated clothing and wash before reuse.
Storage
Store in a well-ventilated place. Keep container tightly closed. Store locked up.
Disposal
Dispose of contents/container in accordance with waste/disposal laws and regulations of your country or particular locality.
2.3 Other hazards
This product contains component(s) which have the following warnings; however based on the GHS classification criteria of your country or locale, the product mixture may be outside the respective category(s). Acute: Possible irritation of the respiratory system can occur causing a variety of symptoms such as dryness of the throat, tightness of the chest, and shortness of breath. Animal tests have indicated that respiratory sensitization can result from skin contact with certain isocyanates. May be harmful if swallowed. Ingestion is not an expected route of entry in industrial or commercial uses. Chronic: May cause long-term lung damage. IARC has designated carbon black as Group 2B - inadequate evidence for carcinogenicity in humans, but sufficient evidence in experimental animals. In 2006 IARC reaffirmed its 1995 finding that there is "inadequate evidence" from human health studies to assess whether carbon black causes cancer in humans. Further, epidemiological evidence from well-conducted investigations has shown no causative link between carbon black exposure and the risk of malignant or non-malignant respiratory disease in humans.
2.1 Classification of the substance or mixture
Acute toxicity Inhalation - Dust and MistCategory 4 - 13.3% of the mixture consists of ingredient(s) of unknown toxicity. Acute toxicity Inhalation - Vapour Category 4 - 13.3% of the mixture consists of ingredient(s) of unknown toxicity. Skin corrosion/irritation Category 2 Serious eye damage/eye irritation Category 2A Skin sensitization Category 1 Respiratory sensitization Category 1 Carcinogenicity Category 2 Specific target organ systemic toxicity (single exposure) Category 3 Specific target organ systemic toxicity (single exposure) Category 1 Respiratory system Specific target organ systemic toxicity (repeated exposure) Category 1 Respiratory system